Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28651 - 28675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	RHOC	389	downregulated	Cytarabine results in decreased expression of RHOC mRNA	1p13.2	A21886
Cytarabine	Approved Investigational	RHPN2	85415	downregulated	Cytarabine results in decreased expression of RHPN2 mRNA	19q13.12	A21886
Cytarabine	Approved Investigational	RNASE2	6036	upregulated	Cytarabine results in increased expression of RNASE2 mRNA	14q11.2	A20985
Cytarabine	Approved Investigational	ROBO3	64221	upregulated	Cytarabine results in increased expression of ROBO3 mRNA	11q24.2	A21886
Cytarabine	Approved Investigational	RPP25	54913	downregulated	Cytarabine results in decreased expression of RPP25 mRNA	15q24.2	A21886
Cytarabine	Approved Investigational	RPRML	388394	upregulated	Cytarabine results in increased expression of RPRML mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	RRAS	6237	downregulated	Cytarabine results in decreased expression of RRAS mRNA	19q13.33	A21886
Cytarabine	Approved Investigational	RRM2	6241	upregulated	Cytarabine results in increased expression of RRM2 mRNA	2p25.1	A20985
Cytarabine	Approved Investigational	RSPO2	340419	downregulated	Cytarabine results in decreased expression of RSPO2 mRNA	8q23.1	A21886
Cytarabine	Approved Investigational	RSRP1	57035	downregulated	Cytarabine results in decreased expression of RSRP1 mRNA	1p36.11	A21886
Cytarabine	Approved Investigational	RTN1	6252	upregulated	Cytarabine results in increased expression of RTN1 mRNA	14q23.1	A21886
Cytarabine	Approved Investigational	RWDD1	51389	upregulated	Cytarabine results in increased expression of RWDD1 mRNA	6q22.1	A21886
Cytarabine	Approved Investigational	S100A10	6281	downregulated	Cytarabine results in decreased expression of S100A10 mRNA	1q21.3	A21886
Cytarabine	Approved Investigational	S100A4	6275	downregulated	Cytarabine results in decreased expression of S100A4 mRNA	1q21.3	A21886
Cytarabine	Approved Investigational	S100P	6286	upregulated	Cytarabine results in increased expression of S100P mRNA	4p16.1	A20985
Cytarabine	Approved Investigational	SARAF	51669	downregulated	Cytarabine results in decreased expression of SARAF mRNA	8p12	A21886
Cytarabine	Approved Investigational	SBSPON	157869	downregulated	Cytarabine results in decreased expression of SBSPON mRNA	8q21.11	A21886
Cytarabine	Approved Investigational	SCAMP5	192683	upregulated	Cytarabine results in increased expression of SCAMP5 mRNA	15q24.2	A21886
Cytarabine	Approved Investigational	SCYL1	57410	downregulated	Cytarabine results in decreased expression of SCYL1 mRNA	11q13.1	A21886
Cytarabine	Approved Investigational	SDC4	6385	downregulated	Cytarabine results in decreased expression of SDC4 mRNA	20q13.12	A21886
Cytarabine	Approved Investigational	SEC14L1	6397	downregulated	Cytarabine results in decreased expression of SEC14L1 mRNA	17q25.2-q25.3	A21886
Cytarabine	Approved Investigational	SELENOM	140606	downregulated	Cytarabine results in decreased expression of SELENOM mRNA	22q12.2	A21886
Cytarabine	Approved Investigational	SEMA5B	54437	upregulated	Cytarabine results in increased expression of SEMA5B mRNA	3q21.1	A21886
Cytarabine	Approved Investigational	SERPINA1	5265	upregulated	Cytarabine results in increased expression of SERPINA1 mRNA	14q32.13	A20985
Cytarabine	Approved Investigational	SERPINB6	5269	downregulated	Cytarabine results in decreased expression of SERPINB6 mRNA	6p25.2	A21886

Displaying entries 28651 - 28675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability